appno,pubdate,pubnum,title,abstract,invs,assignee,xref,filedate,govint,parentcase,childcase,date371,pctpubno
13060194,20110623,20110147317,"Catalytic Compositions, Composition Production Methods, and Aqueous Solution Treatment Methods","Composition production methods are provided that can include providing PdO nanoparticles on a nitrogen-doped titanium oxide surface to form a catalytic mixture. Catalytic compositions and/or bactericides are provided that can include a substrate supporting Ti, O, N, and Pd. Water purification methods are provided that can include exposing an aqueous solution to a composition comprising at least a substrate supporting Ti, O, N, and Pd. Photocatalytic methods are provided that can include: providing a composition comprising one or both of Ti and Pd; exposing the composition to visible radiation to activate the composition; and in the substantial absence of the visible radiation, contacting the composition with an aqueous solution to purify the aqueous solution. Embodiments of the disclosure provide visible light photocatalysts that can demonstrate faster photocatalytic disinfection rates on () under visible light illumination as compared to nitrogen-doped titanium oxide (TiON), as well as catalytic activity after visible light illumination is substantially removed.",[Qi Li][Yin Wai Li][Pinggui Wu][Rongcai Xie][Jian ku Shang],"","This application claims priority under 35 U.S.C. &#xA7;119 to U.S. Provisional Patent Application Ser. No. 61/091,314 entitled &#x201C;Photocatalysts and Photocatalytic Methods&#x201D;, which was filed Aug. 22, 2008, the entirety of which is incorporated by reference herein.",20090824,"This invention was made with Government support by the Center of Advanced Materials for the Purification of Water with Systems, National Science Foundation, under Agreement Number CTS-0120978; Grant Number DEFG02-91-ER45439 awarded by the U.S. Department of Energy. The Government has certain rights in the invention.","","",20110222,PCT/US09/54785
12956665,20110623,20110147578,TIME-OF-FLIGHT SPECTROMETRY AND SPECTROSCOPY OF SURFACES,"Described is an analytical method and apparatus for counting and measuring the flight time of secondary electrons, secondary ions and neutrals, scattered ions and/or neutrals and for correlating coincidences between these while maintaining a continuous un-pulsed, micro-focused, primary particle beam for impinging a surface for purposes of microprobe imaging and microanalysis.",[J. Albert Schultz][Thomas F. Egan][Steven Ulrich][Kelley L. Waters],"[IONWERKS, INC.]","This application claims priority to U.S. provisional patent application 61/264,897, filed Nov. 30, 2009.",20101130,"This invention was developed in part, under Award NO. 0912355 from the National Science Foundation SBIR phase I small business program. The U.S. government may have rights in the invention.","","","",""
12912712,20110623,20110147655,POLAR NEMATIC COMPOUNDS,"Polar nematic compounds, one example of which has the following structure:  is a caged boron structure, where the sphere of the caged boron structure is C and each non-sphere vertex of the caged boron structure is B—H. R is H, an alkyl, a cycloalkyl, a bicycloalkyl, an alkenyl, a cycloalkenyl, a bicycloalkenyl, an alkynyl, an acyl, an aryl, an alkylaryl, a halogen, a cyano group, or an isothiocyanoto group, or R is a group that forms an ether, a ketone, an ester, a thioester, a sulfide, or a sulfone. X is COOR′ or COSR′. R′ is H, an alkyl, a cycloalkyl, a bicycloalkyl, an alkenyl, a cycloalkenyl, a bicycloalkenyl, an alkynyl, an aryl, a halogen, or a cyano group. The compounds may be used in liquid crystal displays (LCDs), and in television sets, laptop computers, computer monitors, hand-held communication devices, gaming devices, watches, cash registers, clocks, and calculators having liquid crystal displays.",[Bryan Ringstrand][Piotr Kaszynski],"","This patent application claims the benefit of U.S. Provisional Application No. 61/287,863, filed Dec. 18, 2009, the content of which is incorporated herein by reference in its entirety.",20101026,This invention was made with government support under DMR-0606317 and DMR-0907542 awarded by the National Science Foundation. The government has certain rights in the invention.,"","","",""
12967367,20110623,20110147702,NITRIDE BASED QUANTUM WELL LIGHT-EMITTING DEVICES HAVING IMPROVED CURRENT INJECTION EFFICIENCY,"A III-nitride based device provides improved current injection efficiency by reducing thermionic carrier escape at high current density. The device includes a quantum well active layer and a pair of multi-layer barrier layers arranged symmetrically about the active layer. Each multi-layer barrier layer includes an inner layer abutting the active layer; and an outer layer abutting the inner layer. The inner barrier layer has a bandgap greater than that of the outer barrier layer. Both the inner and the outer barrier layer have bandgaps greater than that of the active layer. InGaN may be employed in the active layer, AlInN, AlInGaN or AlGaN may be employed in the inner barrier layer, and GaN may be employed in the outer barrier layer. Preferably, the inner layer is thin relative to the other layers. In one embodiment the inner barrier and active layers are 15 Å and 24 Å thick, respectively.",[Nelson Tansu][Hongping Zhao][Guangyu Liu][Ronald Arif],[Lehigh University],"This application claims the benefit of priority under 35 U.S.C. &#xA7;119(e) of U.S. Provisional Patent Application No. 61/286,821, filed Dec. 16, 2009, the entire disclosure of which is hereby incorporated herein by reference.",20101214,"This invention was made with government support under U.S. National Science Foundation&#x2014;ECCS Award #0701421, and US Department of Energy&#x2014;NETL (DE-FC26-08NT01581). The government has certain rights in the invention.","","","",""
12972418,20110623,20110147703,ABBREVIATED EPITAXIAL GROWTH MODE (AGM) METHOD FOR REDUCING COST AND IMPROVING QUALITY OF LEDs AND LASERS,"The use of an abbreviated GaN growth mode on nano-patterned AGOG sapphire substrates, which utilizes a process of using 15 nm low temperature GaN buffer and bypassing etch-back and recovery processes during epitaxy, enables the growth of high-quality GaN template on nano-patterned AGOG sapphire. The GaN template grown on nano-patterned AGOG sapphire by employing abbreviated growth mode has two orders of magnitude lower threading dislocation density than that of conventional GaN template grown on planar sapphire. The use of abbreviated growth mode also leads to significant reduction in cost of the epitaxy. The growths and characteristics of InGaN quantum wells (QWs) light emitting diodes (LEDs) on both templates were compared. The InGaN QWs LEDs grown on the nano-patterned AGOG sapphire demonstrated at least a 24% enhancement of output power enhancement over that of LEDs grown on conventional GaN templates.",[Nelson Tansu][Helen M. Chan][Richard P. Vinci][Yik-Khoon Ee][Jeffrey Biser],[LEHIGH UNIVERSITY],"This application claims the benefit of priority under 35 U.S.C. &#xA7;119(e) of U.S. Provisional Patent Application No. 61/287,353, filed Dec. 17, 2009, the entire disclosure of which is hereby incorporated herein by reference.",20101217,"This invention was made with government support under U.S. Department of Energy (DE-FC26-08NT01581) and US National Science Foundation (ECCS # , and DMR # 0705299). The government has certain rights in the invention.","","","",""
12996924,20110623,20110147715,Medium Scale Carbon Nanotube Thin Film Integrated Circuits on Flexible Plastic Substrates,"The present invention provides device components geometries and fabrication strategies for enhancing the electronic performance of electronic devices based on thin films of randomly oriented or partially aligned semiconducting nanotubes. In certain aspects, devices and methods of the present invention incorporate a patterned layer of randomly oriented or partially aligned carbon nanotubes, such as one or more interconnected SWNT networks, providing a semiconductor channel exhibiting improved electronic properties relative to conventional nanotubes-based electronic systems.",[John A. Rogers][Qing Cao][Muhammad Alam][Ninad Pimparkar],[PURDUE RESEARCH FOUNDATION],"This application claims the benefit of priority to U.S. provisional Patent Applications 61/061,710 filed Jun. 16, 2008 and 61/074,254 filed Jun. 20, 2008, which are hereby incorporated by reference in their entirety.",20090616,This invention was made with government support awarded by the following agencies: National Science Foundation Grant NIRT-0403489 and U.S. Department of Energy Grant DE-FG02-07ER46471. The United States government has certain rights in the invention.,"","",20110301,PCT/US09/47442
13030400,20110623,20110148219,SHORT RANGE EFFICIENT WIRELESS POWER TRANSFER,"Described herein are embodiments of an electronic system that includes a magnetically coupled resonance system, that includes a first surface against which devices to be provided with power are located, and providing power to said devices on said first surface, and providing power to other devices that are not on said first surface, each of said devices receiving said power using magnetically coupled resonance between at least one high-Q source magnetic resonator adjacent to said first surface, and a high-Q device magnetic resonator in at least one device.",[Aristeidis Karalis][Andre B. Kurs][Robert Moffatt][John D. Joannopoulos][Peter H. Fisher][Marin Soljacic],"","This application is a continuation of U.S. patent application Ser. No. 12/688,339 ('339 application) filed Jan. 15, 2010, the entirety of which is incorporated herein by reference. The '339 application is a continuation to U.S. patent application Ser. No. 12/055,963 ('963 application), filed Mar. 26, 2008 the entirety of which is incorporated herein by reference. The '963 application claims the benefit of the following provisional applications, each of which is incorporated herein by reference in its entirety: U.S. Provisional Patent Application 60/908,383 filed Mar. 27, 2007; and U.S. Provisional Patent Application 60/908,666, filed Mar. 28, 2007.The '963 application is a continuation-in-part of co-pending U.S. patent application entitled WIRELESS NON-RADIATIVE ENERGY TRANSFER filed on Jul. 5, 2006 and having Ser. No. 11/481,077 ('077 application), the entirety of which is incorporated herein by reference. The '077 Application claims the benefit of provisional application Ser. No. 60/698,442 filed Jul. 12, 2005 ('442 application), the entirety of which is incorporated herein by reference.The '963 application, pursuant to U.S.C. &#xA7;120 and U.S.C. &#xA7;363, is a continuation-in-part of International Application No. PCT/US2007/070892, filed Jun. 11, 2007, which is incorporated herein by reference in its entirety, and which claims priority to the following provisional applications, each of which is incorporated herein by reference in its entirety: U.S. Provisional Patent Application 60/908,383 filed Mar. 27, 2007; and U.S. Provisional Patent Application 60/908,666, filed Mar. 28, 2007.",20110218,This invention was made with government support awarded by the National Science Foundation under Grant No. DMR 02-13282. The government has certain rights in this invention.,12688339,13030400,"",""
12832583,20110623,20110149382,Apparatuses and Methods for Performing Gain Guiding,"A fiber, such as a photonic bandgap fiber, is provided, the fiber including a core and a cladding. The core can extend longitudinally and can have a gain medium configured to provide laser amplification to laser radiation propagating along the core. For example, the gain medium may include a dopant configured to provide amplification, when activated by one or more modes of excitation radiation, of laser radiation propagating along said core. The cladding can be radially exterior to the core, and can be configured to provide a low-loss propagation the one or more modes of excitation radiation and a lossy propagation of all modes of laser radiation along the core, the lossy propagation higher than the low-loss propagation, in particular when the one or more modes of excitation radiation is substantially absent from the core. Associated methods and apparatuses are also provided.",[Tsinghua Her],[UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE],"This application is a continuation of International Application No. PCT/US2008/085565, filed on Dec. 4, 2008, which claims the benefit of U.S. Provisional Patent Application No. 61/019,680 filed Jan. 8, 2008, and U.S. Provisional Patent Application No. 61/263,858, filed Nov. 24, 2009, all of which are incorporated by reference herein in their entirety.",20100708,"This invention was made with United States Government support under Grant No. W911NF-05-1-0517 awarded by the U.S. Army Research Office, and under Grant No. HR0011-08-1-0065 awarded by the Defense Advanced Research Projects Agency, and under Grant No. 0925992 awarded by the National Science Foundation. The United States Government may have certain rights in the invention.",PCT/US2008/085565,12832583,"",""
13020660,20110623,20110150779,DYNAMIC NUCLEAR POLARIZATION ENHANCED NUCLEAR MAGNETIC RESONANCE OF WATER UNDER AMBIENT CONDITIONS,"A method and apparatus are provided for treating hydrated material in a fluid that contains water in which a stable nitroxide is attached to the hydrated material. A dynamic nuclear polarization process (DNP) is conducted on the hydrated material whereby to hyperpolarize the water. A polarization cell contains the hydrated material to obtain hyperpolarized water free from the nitroxide. The dynamic nuclear polarization process is conducted using components comprising a tunable, solid state high power X-band driver and an X-band resonator for microwave transmission to the hydrated material. The components can also include a radio-frequency nuclear magnetic resonance probe, a permanent magnet formed to receive the hydrated material, a portable nuclear magnetic resonance spectrometer, and an electron spin resonance detector. The components can be sized to be portable, and include electrical input and output and a lap-size hard-case with access to the electrical input and output.",[Songi Han][Evan R. McCarney][Brandon D. Armstrong][Ravinath Kausik][Hanna Pavlova][Mark Lingwood][Elliott Brown],"","This application claims the benefit of Provisional Patent Application No. 60/966,117, filed Aug. 24, 2007, No. 61/010,467, filed Jan. 9, 2008, and No. 61/132,384, filed Jun. 18, 2008.",20110203,"This invention was made with Government support under Grant Nos. DMR 00-80034, DMR 05-20415 and CHE-0645536, all from the National Science Foundation. The Government has certain rights in this invention.",12229540,13020660,"",""
13033352,20110623,20110150854,"RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES","It has been discovered that certain natural mRNAs serve as metabolite-sensitive genetic switches wherein the RNA directly binds a small organic molecule. This binding process changes the conformation of the mRNA, which causes a change in gene expression by a variety of different mechanisms. Modified versions of these natural “riboswitches” (created by using various nucleic acid engineering strategies) can be employed as designer genetic switches that are controlled by specific effector compounds. Such effector compounds that activate a riboswitch are referred to herein as trigger molecules. The natural switches are targets for antibiotics and other small molecule therapies. In addition, the architecture of riboswitches allows actual pieces of the natural switches to be used to construct new non-immunogenic genetic control elements, for example the aptamer (molecular recognition) domain can be swapped with other non-natural aptamers (or otherwise modified) such that the new recognition domain causes genetic modulation with user-defined effector compounds. The changed switches become part of a therapy regimen—turning on, or off, or regulating protein synthesis. Newly constructed genetic regulation networks can be applied in such areas as living biosensors, metabolic engineering of organisms, and in advanced forms of gene therapy treatments.",[Ronald R. Breaker][Ali Nahvi][Narasimhan Sudarsan][Margaret S. Ebert][Wade Winkler][Jeffrey E. Barrick][John K. Wickiser],[],"This application is a Divisional application of U.S. application Ser. No. 12/492,866, filed Jun. 26, 2009, which is a Divisional application of U.S. application Ser. No. 10/669,162, filed Sep. 22, 2003, which claims benefit of U.S. Provisional Application No. 60/412,468, filed Sep. 20, 2002. U.S. application Ser. No. 12/492,866, filed Jun. 26, 2009, U.S. application Ser. No. 10/669,162, filed Sep. 22, 2003, and U.S. Provisional Application No. 60/412,468, filed Sep. 20, 2002, are hereby incorporated herein by reference in their entirety.",20110223,"This invention was made with government support under Grants NIH GM48858 and NIH GM559343 awarded by the National Institutes of Health, and Grant NSF EIA-0129939 awarded by the National Science Foundation. The government has certain rights in the invention.",12492866,13033352,"",""
12672447,20110623,20110150938,Supercrystalline Colloidal Particles and Method of Production,"The present invention concerns size- and shape-controlled, colloidal superparticles (SPs) and methods for synthesizing the same. Ligand-functionalized nanoparticles such as nonpolar-solvent-dispersible nanoparticles, are used, and the solvophobic interactions can be controlled. Advantageously, supercrystalline SPs having a superlattice structure, such as a face-centered cubic structure, can be produced. Further, the methods of the invention can provide SPs that self-assemble and are monodisperse. The SPs can be doped with organic dyes and further assembled into more complex structures.",[Y. Charles Cao][Jiaqi Zhuang][Huimeng Wu][Yongan Yang],"[University of Florida Research Foundation, Inc.]","The present application claims the benefit of U.S. Provisional Application Ser. No. 60/956,625, filed Aug. 17, 2007, which is hereby incorporated by reference herein in its entirety, including any figures, tables, nucleic acid sequences, amino acid sequences, and drawings.",20080815,"The subject matter of this application has been supported by research grants from the National Science Foundation under grant number DMR-0645520 and the Office of Naval Research under grant number N00014-06-1-0911. Accordingly, the government has certain rights in this invention.","","",20110304,PCT/US08/73295
12599286,20110623,20110151190,SHADOW EDGE LITHOGRAPHY FOR NANOSCALE PATTERNING AND MANUFACTURING,"An advanced high-resolution and high-throughput shadow edge () lithography (SEL) method is disclosed for forming uniform zero- one- and two-dimensional nanostructures on a substrate. The method entails high-vacuum oblique vapor deposition and a compensated shadow effect of a pre-patterned layer (). A method of compensating for cross-substrate variation is also disclosed. The compensation approach enables routine, low-cost fabrication of uniform nanoscale features, or nanogaps () on the order of 10 nm±1 nm, that can be used to etch nanowells () or to form nanostructures such as nanowires (), using a selective metal lift-off process. A wafer-scale analytical model is proposed for predicting the width of nanogaps () fabricated by the shadow effect on pre-patterned edges. By combining compensation and pattern reversal techniques with multiple shadow patterning, two-dimensional structures such as crossing nanowires may be generated. A technique is disclosed for smoothing edge roughness of the nanostructures.",[Jae-Hyun Chung][Guofeng Bai][Woon-Hong Yeo],"","This application claims the benefit under 35 U.S.C. &#xA7;119(e) from U.S. Provisional Patent Application No. 60/916,777, filed May 8, 2007, which is incorporated herein by reference.",20080508,This invention was made with U.S. Government support under grant contract No. CMMI0624597 awarded by the National Science Foundation. The U.S. Government has certain rights in the invention.,"","",20091106,PCT/US08/63113
13033258,20110623,20110151471,"RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES","It has been discovered that certain natural mRNAs serve as metabolite-sensitive genetic switches wherein the RNA directly binds a small organic molecule. This binding process changes the conformation of the mRNA, which causes a change in gene expression by a variety of different mechanisms. Modified versions of these natural “riboswitches” (created by using various nucleic acid engineering strategies) can be employed as designer genetic switches that are controlled by specific effector compounds. Such effector compounds that activate a riboswitch are referred to herein as trigger molecules. The natural switches are targets for antibiotics and other small molecule therapies. In addition, the architecture of riboswitches allows actual pieces of the natural switches to be used to construct new non-immunogenic genetic control elements, for example the aptamer (molecular recognition) domain can be swapped with other non-natural aptamers (or otherwise modified) such that the new recognition domain causes genetic modulation with user-defined effector compounds. The changed switches become part of a therapy regimen—turning on, or off, or regulating protein synthesis. Newly constructed genetic regulation networks can be applied in such areas as living biosensors, metabolic engineering of organisms, and in advanced forms of gene therapy treatments.",[Ronald R. Breaker][Ali Nahvi][Narasimhan Sudarsan][Margaret S. Ebert][Wade Winkler][Jeffrey E. Barrick][John K. Wickiser],[],"This application is a Divisional Application of U.S. application Ser. No. 12/492,866, filed Jun. 26, 2009, which is a Divisional Application of U.S. application Ser. No. 10/669,162, filed Sep. 22, 2003, which claims benefit of U.S. Provisional Application No. 60/412,468, filed Sep. 20, 2002. U.S. application Ser. No. 12/492,866, filed Jun. 26, 2009, U.S. application Ser. No. 10/669,162, filed Sep. 22, 2003, and U.S. Provisional Application No. 60/412,468, filed Sep. 20, 2002, are hereby incorporated herein by reference in their entirety.",20110223,"This invention was made with government support under Grants NIH GM48858 and NIH GM559343 awarded by the National Institutes of Health, and Grant NSF EIA-0129939 awarded by the National Science Foundation. The government has certain rights in the invention.",12492866,13033258,"",""
12992376,20110623,20110151578,VALVES AND OTHER FLOW CONTROL IN FLUIDIC SYSTEMS INCLUDING MICROFLUIDIC SYSTEMS,"Articles and methods for controlling flow in fluidic Systems, especially in microfluidic Systems, are provided. A microfluidic System includes a configuration such that the actuation of a single valve can allow the switching of fluids from a first fluid path (e.g., a first channel section) to a second fluid path (e.g., a second channel section). This may be achieved by incorporating a valve () with a first channel section (), which may have a lower hydrodynamic resistance than a second channel section () prior to actuation of the valve. Actuation of the valve () can cause only the hydrodynamic resistance of the first channel section () to increase, thereby redirecting fluid flow into the second channel section () (which now has a relatively lower hydrodynamic resistance). The valve comprises a control channel () for introducing a positive or reduced pressure, and is adapted to modulate fluid flow in an adjacent channel section by constricting or expanding the channel section ().",[Adam R. Abate][David A. Weitz],[President and Fellows of Harvard College],"",20090515,"Research leading to various aspects of the present invention was sponsored, at least in part, by the NSF, under Grant Nos. DMR-0602684, DBI-0649865 and DMR-0213805. The U.S. Government has certain rights in the invention.","","",20110307,PCT/US09/03024
12918785,20110623,20110151615,"BICYCLIC GUANIDINES, METAL COMPLEXES THEREOF AND THEIR USE IN VAPOR DEPOSITION","Bicyclic guanidine compounds are described. Metal bicyclic guanidinate and its use in vapor deposition processes to deposit a metal-containing thin film are also described. Methods of making alkaline earth metal N,N′dialkylacetamidinates or bicyclic guanidinates including dissolution of alkaline earth metal into liquid ammonia followed by addition of a solution of an amidine or guanidine ligand in the free base from are provided.",[Roy G. Gordon][Leonard Neil Jacques Rodriguesz],[President and Fellows of Harvard College],"This application is related to U.S. patent application Ser. No. 10/534,687 filed on Nov. 14, 2003, entitled &#x201C;Atomic layer deposition using metal amidinates,&#x201D; which is incorporated herein by reference in its entirety.This application is related to U.S. Provisional Patent Application No. 60/817,209 filed on Jun. 28, 2006, entitled &#x201C;Metal(IV) Tetra-Amidinate Compounds And Their Use In Vapor Deposition,&#x201D; which is incorporated herein by reference in its entirety.This application claims the benefit of priority under 35 U.S.C. &#xA7;119(e) to copending U.S. Application No. 61/030,063, filed Feb. 20, 2008, and entitled &#x201C;Guanidines, Metal Complexes Thereof and Their Use in Vapor Deposition,&#x201D; which is hereby incorporated in its entirety by reference.",20090220,The present invention was made with United States government support under Grant No. 0354213 awarded by the National Science Foundation. The United States government may have certain rights in this invention.,"","",20110224,PCT/US09/34708
13033174,20110623,20110152213,"RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES","It has been discovered that certain natural mRNAs serve as metabolite-sensitive genetic switches wherein the RNA directly binds a small organic molecule. This binding process changes the conformation of the mRNA, which causes a change in gene expression by a variety of different mechanisms. Modified versions of these natural “riboswitches” (created by using various nucleic acid engineering strategies) can be employed as designer genetic switches that are controlled by specific effector compounds. Such effector compounds that activate a riboswitch are referred to herein as trigger molecules. The natural switches are targets for antibiotics and other small molecule therapies. In addition, the architecture of riboswitches allows actual pieces of the natural switches to be used to construct new non-immunogenic genetic control elements, for example the aptamer (molecular recognition) domain can be swapped with other non-natural aptamers (or otherwise modified) such that the new recognition domain causes genetic modulation with user-defined effector compounds. The changed switches become part of a therapy regimen—turning on, or off, or regulating protein synthesis. Newly constructed genetic regulation networks can be applied in such areas as living biosensors, metabolic engineering of organisms, and in advanced forms of gene therapy treatments.",[Ronald R. Breaker][Ali Nahvi][Narasimhan Sudarsan][Margaret S. Ebert][Wade Winkler][Jeffrey E. Barrick][John K. Wickiser],[],"This application is a Divisional Application of U.S. application Ser. No. 12/492,866, filed Jun. 26, 2009, which is a Divisional Application of U.S. application Ser. No. 10/669,162, filed Sep. 22, 2003, which claims benefit of U.S. Provisional Application No. 60/412,468, filed Sep. 20, 2002. U.S. application Ser. No. 12/492,866, filed Jun. 26, 2009, U.S. application Ser. No. 10/669,162, filed Sep. 22, 2003, and U.S. Provisional Application No. 60/412,468, filed Sep. 20, 2002, are hereby incorporated herein by reference in their entirety.",20110223,"This invention was made with government support under Grants NIH GM48858 and NIH GM559343 awarded by the National Institutes of Health, and Grant NSF EIA-0129939 awared by the National Science Foundation. The government has certain rights in the invention.",12492866,13033174,"",""
13033319,20110623,20110152215,"RIBOSWITCHES, METHODS FOR THEIR USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES","It has been discovered that certain natural mRNAs serve as metabolite-sensitive genetic switches wherein the RNA directly binds a small organic molecule. This binding process changes the conformation of the mRNA, which causes a change in gene expression by a variety of different mechanisms. Modified versions of these natural “riboswitches” (created by using various nucleic acid engineering strategies) can be employed as designer genetic switches that are controlled by specific effector compounds. Such effector compounds that activate a riboswitch are referred to herein as trigger molecules. The natural switches are targets for antibiotics and other small molecule therapies. In addition, the architecture of riboswitches allows actual pieces of the natural switches to be used to construct new non-immunogenic genetic control elements, for example the aptamer (molecular recognition) domain can be swapped with other non-natural aptamers (or otherwise modified) such that the new recognition domain causes genetic modulation with user-defined effector compounds. The changed switches become part of a therapy regimen—turning on, or off, or regulating protein synthesis. Newly constructed genetic regulation networks can be applied in such areas as living biosensors, metabolic engineering of organisms, and in advanced forms of gene therapy treatments.",[Ronald R. Breaker][Ali Nahvi][Narasimhan Sudarsan][Margaret S. Ebert][Wade Winkler][Jeffrey E. Barrick][John K. Wickiser],[],"This application is a Divisional application of U.S. application Ser. No. 12/492,866, filed Jun. 26, 2009, which is a Divisional application of U.S. application Ser. No. 10/669,162, filed Sep. 22, 2003, which claims benefit of U.S. Provisional Application No. 60/412,468, filed Sep. 20, 2002. U.S. application Ser. No. 12/492,866, filed Jun. 26, 2009, U.S. application Ser. No. 10/669,162, filed Sep. 22, 2003, and U.S. Provisional Application No. 60/412,468, filed Sep. 20, 2002, are hereby incorporated herein by reference in their entirety.",20110223,"This invention was made with government support under Grants NIH GM48858 and NIH GM559343 awarded by the National Institutes of Health, and Grant NSF EIA-0129939 awarded by the National Science Foundation. The government has certain rights in the invention.",12492866,13033319,"",""
12987300,20110623,20110154539,CONTROL OF FRUIT DEHISCENCE IN PLANTS BY INDEHISCENT1 GENES,The present application provides methods and compositions that modulate fruit dehiscence in plants.,[Martin F. Yanofsky][Sarah Liljegren],[],"This application is a continuation-in-part of U.S. application Ser. No. 09/548,971, filed on Apr. 13, 2000, which is a continuation-in-part of U.S. application Ser. No. 09/339,998, filed on Jun. 25, 1999, which claims benefit of priority to U.S. Provisional Application No. 60/090,649, filed Jun. 25, 1998, each of which is incorporated by reference in its entirety.",20110110,This invention was made with Government support under National Science Foundation Grant number IBN-9985530. The Government has certain rights in the invention.,11594053,12987300,"",""
